Gabriele Marchetti

Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience

M. Falcone, L. Puccetti, N. Riccardi, 2022, Infectious Diseases and Therapy.